| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 COL1A2 | 2.46e-15 | 46 | 81 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 COL1A2 | 4.53e-09 | 188 | 81 | 10 | GO:0005201 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 MMP9 COL1A2 | 1.99e-08 | 377 | 79 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 MMP9 COL1A2 | 2.05e-08 | 378 | 79 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 MMP9 COL1A2 | 2.11e-08 | 379 | 79 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 9.64e-08 | 12 | 79 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 5.85e-07 | 18 | 79 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | skeletal system development | COL9A1 COL19A1 GLI2 DLL3 PKD1 AKAP13 LTBP3 ACVR2B MMP9 GDF2 COL1A2 | 2.18e-05 | 615 | 79 | 11 | GO:0001501 |
| GeneOntologyBiologicalProcess | biomineral tissue development | 1.29e-04 | 203 | 79 | 6 | GO:0031214 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 1.35e-04 | 68 | 79 | 4 | GO:0007528 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 WDR33 COL5A3 COL1A2 | 4.23e-14 | 88 | 82 | 11 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.22e-12 | 21 | 82 | 7 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 4.91e-12 | 6 | 82 | 5 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 4.55e-11 | 8 | 82 | 5 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 4.55e-11 | 8 | 82 | 5 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 4.55e-11 | 8 | 82 | 5 | GO:0098645 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 ARSA COL19A1 COL5A3 COL1A2 | 7.05e-08 | 332 | 82 | 11 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 LTBP3 MMP9 COL1A2 | 1.40e-07 | 530 | 82 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 LTBP3 MMP9 COL1A2 | 1.55e-06 | 656 | 82 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 LTBP3 MMP9 COL1A2 | 1.60e-06 | 658 | 82 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 1.19e-04 | 122 | 82 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 9.78e-04 | 12 | 82 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 9.78e-04 | 12 | 82 | 2 | GO:0098643 | |
| HumanPheno | Glomerular basement membrane lamellation | 2.48e-07 | 3 | 33 | 3 | HP:0030034 | |
| HumanPheno | Lenticonus | 2.88e-05 | 10 | 33 | 3 | HP:0001142 | |
| HumanPheno | Thickened glomerular basement membrane | 5.24e-05 | 12 | 33 | 3 | HP:0004722 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 6.78e-05 | 13 | 33 | 3 | HP:0033282 | |
| HumanPheno | Glomerular subepithelial deposits | 8.59e-05 | 14 | 33 | 3 | HP:0033603 | |
| HumanPheno | Anterior lenticonus | 1.22e-04 | 3 | 33 | 2 | HP:0011501 | |
| HumanPheno | Thin glomerular basement membrane | 1.22e-04 | 3 | 33 | 2 | HP:0012577 | |
| MousePheno | podocyte foot process effacement | 8.95e-07 | 38 | 66 | 5 | MP:0008140 | |
| MousePheno | hematuria | 1.67e-06 | 19 | 66 | 4 | MP:0005161 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 1.89e-06 | 44 | 66 | 5 | MP:0011348 | |
| MousePheno | abnormal podocyte foot process morphology | 5.83e-06 | 55 | 66 | 5 | MP:0008059 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 7.33e-06 | 27 | 66 | 4 | MP:0011409 | |
| MousePheno | albuminuria | 1.14e-05 | 63 | 66 | 5 | MP:0002871 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 1.30e-05 | 31 | 66 | 4 | MP:0011349 | |
| MousePheno | renal cast | 1.89e-05 | 34 | 66 | 4 | MP:0011402 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 1.92e-05 | 70 | 66 | 5 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 1.92e-05 | 70 | 66 | 5 | MP:0005326 | |
| MousePheno | abnormal sexual interaction | 7.98e-05 | 94 | 66 | 5 | MP:0002566 | |
| MousePheno | abnormal joint morphology | 9.70e-05 | 397 | 66 | 9 | MP:0002932 | |
| MousePheno | renal interstitial fibrosis | 1.20e-04 | 54 | 66 | 4 | MP:0003215 | |
| MousePheno | postnatal lethality | COL4A1 COL4A2 COL19A1 GLI2 DOK7 CLTA DLL3 ARX PKD1 GATA2 EHMT1 ETV5 SMARCC2 ACVR2B FAM83H | 1.25e-04 | 1084 | 66 | 15 | MP:0002082 |
| MousePheno | buphthalmos | 1.31e-04 | 4 | 66 | 2 | MP:0009274 | |
| MousePheno | abnormal renal glomerular capsule morphology | 1.48e-04 | 107 | 66 | 5 | MP:0002828 | |
| MousePheno | renal glomerular synechia | 2.18e-04 | 5 | 66 | 2 | MP:0011483 | |
| MousePheno | anterior polar cataract | 2.18e-04 | 5 | 66 | 2 | MP:0010259 | |
| MousePheno | abnormal esophagus development | 2.18e-04 | 5 | 66 | 2 | MP:0003160 | |
| MousePheno | abnormal esophageal smooth muscle morphology | 2.18e-04 | 5 | 66 | 2 | MP:0003159 | |
| MousePheno | postnatal lethality, incomplete penetrance | COL4A1 COL19A1 GLI2 CLTA DLL3 ARX GATA2 EHMT1 ETV5 ACVR2B FAM83H | 2.69e-04 | 669 | 66 | 11 | MP:0011086 |
| MousePheno | abnormal kidney interstitium morphology | 2.78e-04 | 67 | 66 | 4 | MP:0011425 | |
| MousePheno | glomerulosclerosis | 2.94e-04 | 68 | 66 | 4 | MP:0005264 | |
| MousePheno | polar cataract | 3.25e-04 | 6 | 66 | 2 | MP:0010258 | |
| MousePheno | renal tubule atrophy | 3.73e-04 | 30 | 66 | 3 | MP:0011346 | |
| MousePheno | decreased circulating protein level | COL4A2 COL4A3 COL4A4 COL4A5 NPTXR PKD1 EHMT1 MYOZ3 MMP9 OPLAH COL1A2 | 3.87e-04 | 698 | 66 | 11 | MP:0014502 |
| MousePheno | pale kidney | 4.96e-04 | 33 | 66 | 3 | MP:0004969 | |
| MousePheno | renal fibrosis | 4.97e-04 | 78 | 66 | 4 | MP:0003985 | |
| MousePheno | abnormal bone ossification | 5.19e-04 | 395 | 66 | 8 | MP:0008271 | |
| MousePheno | abnormal brain internal capsule morphology | 5.42e-04 | 34 | 66 | 3 | MP:0008128 | |
| MousePheno | abnormal muscle morphology | COL4A1 COL4A2 MYLK3 COL19A1 ADAMTS2 MAPT GLI2 DLL3 PKD1 ANKRD17 AKAP13 IRS2 MMP9 COL1A2 | 5.44e-04 | 1106 | 66 | 14 | MP:0002108 |
| MousePheno | macrophthalmia | 6.04e-04 | 8 | 66 | 2 | MP:0001296 | |
| MousePheno | abnormal glomerular mesangium morphology | 6.29e-04 | 83 | 66 | 4 | MP:0011339 | |
| MousePheno | increased urine protein level | 6.82e-04 | 149 | 66 | 5 | MP:0002962 | |
| MousePheno | abnormal renal tubule morphology | 6.92e-04 | 227 | 66 | 6 | MP:0002703 | |
| MousePheno | increased large unstained cell number | 7.54e-04 | 38 | 66 | 3 | MP:0012362 | |
| MousePheno | dilated glomerular capillary | 7.74e-04 | 9 | 66 | 2 | MP:0011509 | |
| MousePheno | abnormal knee joint morphology | 7.74e-04 | 9 | 66 | 2 | MP:0030837 | |
| MousePheno | irregularly shaped pupil | 8.14e-04 | 39 | 66 | 3 | MP:0001319 | |
| MousePheno | polyuria | 8.19e-04 | 89 | 66 | 4 | MP:0001762 | |
| MousePheno | abnormal temporal memory | 9.05e-04 | 239 | 66 | 6 | MP:0001468 | |
| MousePheno | polycystic kidney | 9.27e-04 | 92 | 66 | 4 | MP:0008528 | |
| MousePheno | abnormal capillary morphology | 9.65e-04 | 93 | 66 | 4 | MP:0003658 | |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 WDR33 COL5A3 COL1A2 | 6.25e-14 | 85 | 79 | 11 | IPR008160 |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 WDR33 COL5A3 COL1A2 | 6.25e-14 | 85 | 79 | 11 | PF01391 |
| Domain | C4 | 7.12e-12 | 6 | 79 | 5 | SM00111 | |
| Domain | - | 7.12e-12 | 6 | 79 | 5 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 7.12e-12 | 6 | 79 | 5 | IPR001442 | |
| Domain | C4 | 7.12e-12 | 6 | 79 | 5 | PF01413 | |
| Domain | NC1_IV | 7.12e-12 | 6 | 79 | 5 | PS51403 | |
| Domain | TSPN | 2.47e-06 | 23 | 79 | 4 | SM00210 | |
| Domain | - | 3.04e-06 | 95 | 79 | 6 | 2.60.120.200 | |
| Domain | Laminin_G | 4.58e-06 | 58 | 79 | 5 | IPR001791 | |
| Domain | CTDL_fold | 6.08e-06 | 107 | 79 | 6 | IPR016187 | |
| Domain | Fib_collagen_C | 1.17e-05 | 11 | 79 | 3 | IPR000885 | |
| Domain | COLFI | 1.17e-05 | 11 | 79 | 3 | PF01410 | |
| Domain | NC1_FIB | 1.17e-05 | 11 | 79 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 1.17e-05 | 11 | 79 | 3 | PD002078 | |
| Domain | COLFI | 1.17e-05 | 11 | 79 | 3 | SM00038 | |
| Domain | PUFD | 1.77e-05 | 2 | 79 | 2 | IPR032365 | |
| Domain | BCOR | 1.77e-05 | 2 | 79 | 2 | PF15808 | |
| Domain | BCOR | 1.77e-05 | 2 | 79 | 2 | IPR031628 | |
| Domain | PUFD | 1.77e-05 | 2 | 79 | 2 | PF16553 | |
| Domain | NUT | 1.75e-04 | 5 | 79 | 2 | IPR024310 | |
| Domain | NUT_N | 1.75e-04 | 5 | 79 | 2 | IPR024309 | |
| Domain | NUT | 1.75e-04 | 5 | 79 | 2 | PF12881 | |
| Domain | hEGF | 2.21e-04 | 28 | 79 | 3 | PF12661 | |
| Domain | ConA-like_dom | 3.31e-04 | 219 | 79 | 6 | IPR013320 | |
| Domain | Laminin_G_2 | 6.43e-04 | 40 | 79 | 3 | PF02210 | |
| Domain | ZnF_GATA | 1.13e-03 | 12 | 79 | 2 | SM00401 | |
| Domain | IRS_PTB | 1.13e-03 | 12 | 79 | 2 | PS51064 | |
| Domain | IRS_PTB | 1.56e-03 | 14 | 79 | 2 | IPR002404 | |
| Domain | IRS | 1.56e-03 | 14 | 79 | 2 | PF02174 | |
| Domain | Znf_GATA | 1.79e-03 | 15 | 79 | 2 | IPR000679 | |
| Domain | GATA | 1.79e-03 | 15 | 79 | 2 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 2.04e-03 | 16 | 79 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 2.04e-03 | 16 | 79 | 2 | PS50114 | |
| Domain | - | 4.02e-03 | 248 | 79 | 5 | 1.25.40.20 | |
| Domain | Ankyrin_rpt-contain_dom | 4.45e-03 | 254 | 79 | 5 | IPR020683 | |
| Domain | GPS | 9.08e-03 | 34 | 79 | 2 | SM00303 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 COL1A2 | 1.13e-15 | 44 | 57 | 10 | M27812 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 MMP9 COL1A2 | 1.20e-15 | 90 | 57 | 12 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 COL1A2 | 1.84e-15 | 67 | 57 | 11 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 COL19A1 ADAMTS2 COL5A3 MMP9 COL1A2 | 7.97e-15 | 76 | 57 | 11 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL5A3 MMP9 COL1A2 | 3.92e-14 | 61 | 57 | 10 | M27103 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 COL19A1 ADAMTS2 COL5A3 COL1A2 | 3.92e-14 | 61 | 57 | 10 | MM14637 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 COL19A1 COL5A3 COL1A2 | 4.73e-14 | 41 | 57 | 9 | MM15538 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 COL19A1 COL5A3 MMP9 COL1A2 | 6.52e-14 | 64 | 57 | 10 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 COL5A3 MMP9 COL1A2 | 3.29e-13 | 50 | 57 | 9 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL19A1 COL5A3 MMP9 COL1A2 | 5.76e-13 | 53 | 57 | 9 | MM14566 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.98e-13 | 20 | 57 | 7 | MM15061 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.62e-11 | 15 | 57 | 6 | M27161 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.76e-11 | 32 | 57 | 7 | MM14924 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 5.96e-11 | 18 | 57 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 5.96e-11 | 18 | 57 | 6 | MM14882 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.38e-10 | 38 | 57 | 7 | MM14969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 LTBP3 MMP9 COL1A2 | 1.50e-10 | 300 | 57 | 13 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 COL19A1 COL5A3 MMP9 COL1A2 | 1.96e-10 | 140 | 57 | 10 | M587 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.24e-10 | 10 | 57 | 5 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.24e-10 | 10 | 57 | 5 | MM1560 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.92e-10 | 42 | 57 | 7 | M7169 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 COL19A1 ADAMTS2 COL5A3 LTBP3 MMP9 COL1A2 | 3.73e-10 | 258 | 57 | 12 | MM14572 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.10e-10 | 11 | 57 | 5 | M15422 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 5.72e-10 | 46 | 57 | 7 | M198 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.54e-10 | 76 | 57 | 8 | MM14867 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.54e-10 | 76 | 57 | 8 | M27219 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL19A1 COL5A3 MMP9 COL1A2 | 6.99e-10 | 114 | 57 | 9 | MM14571 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 7.00e-10 | 12 | 57 | 5 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.13e-09 | 13 | 57 | 5 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.13e-09 | 13 | 57 | 5 | M12950 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.62e-09 | 85 | 57 | 8 | M16441 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.76e-09 | 14 | 57 | 5 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.76e-09 | 14 | 57 | 5 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.63e-09 | 15 | 57 | 5 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.73e-09 | 57 | 57 | 7 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.09e-09 | 58 | 57 | 7 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.50e-09 | 59 | 57 | 7 | M27218 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.61e-09 | 63 | 57 | 7 | M11187 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.34e-08 | 20 | 57 | 5 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.88e-08 | 23 | 57 | 5 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.88e-08 | 23 | 57 | 5 | MM1427 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 CLTA COL5A3 IRS2 MMP9 | 8.00e-08 | 261 | 57 | 10 | MM15676 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 THEM4 CLTA COL5A3 IRS2 MMP9 COL1A2 | 8.34e-08 | 418 | 57 | 12 | MM15587 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.19e-07 | 30 | 57 | 5 | M27216 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 THEM4 CLTA COL5A3 IRS2 MMP9 COL1A2 | 1.45e-07 | 532 | 57 | 13 | M27870 |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.50e-07 | 161 | 57 | 8 | M39770 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 5.00e-07 | 74 | 57 | 6 | M160 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 7.73e-07 | 43 | 57 | 5 | M53 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.69e-06 | 66 | 57 | 5 | M18 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 UPF2 CLTA COL5A3 IRS2 MMP9 | 1.58e-05 | 575 | 57 | 11 | M29853 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.19e-05 | 84 | 57 | 5 | M7098 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.64e-05 | 43 | 57 | 4 | M39565 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 CLTA COL5A3 IRS2 MMP9 | 2.87e-05 | 502 | 57 | 10 | MM14537 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.17e-05 | 96 | 57 | 5 | M39834 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 5.80e-05 | 19 | 57 | 3 | M27221 | |
| Pathway | WP_PI3KAKT_SIGNALING | 6.09e-05 | 339 | 57 | 8 | M39736 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 UPF2 ZNF335 CLTA DLL3 GATA2 SMARCC2 COL5A3 IRS2 ACVR2B MMP9 | 1.21e-04 | 1432 | 57 | 16 | M509 |
| Pathway | WP_FOCAL_ADHESION | 1.46e-04 | 199 | 57 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.46e-04 | 199 | 57 | 6 | M7253 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.91e-04 | 28 | 57 | 3 | MM15957 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.35e-04 | 30 | 57 | 3 | M27772 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 3.14e-04 | 33 | 57 | 3 | M39870 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.99e-04 | 41 | 57 | 3 | M27778 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 7.88e-04 | 45 | 57 | 3 | M39864 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.96e-04 | 47 | 57 | 3 | MM14925 | |
| Pathway | WP_FOCAL_ADHESION | 9.33e-04 | 187 | 57 | 5 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.33e-03 | 302 | 57 | 6 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.97e-03 | 326 | 57 | 6 | MM15917 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.63e-03 | 19 | 57 | 2 | MM15512 | |
| Pathway | PID_AP1_PATHWAY | 2.83e-03 | 70 | 57 | 3 | M167 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.07e-03 | 72 | 57 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.19e-03 | 73 | 57 | 3 | MM15906 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119 | 3.52e-03 | 22 | 57 | 2 | M47924 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.99e-03 | 79 | 57 | 3 | M27643 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 4.05e-03 | 161 | 57 | 4 | M27871 | |
| Pathway | WP_CANCER_PATHWAYS | 4.16e-03 | 507 | 57 | 7 | M48302 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.74e-03 | 84 | 57 | 3 | M3228 | |
| Pathway | PID_ALK1_PATHWAY | 4.91e-03 | 26 | 57 | 2 | M185 | |
| Pubmed | 1.45e-17 | 9 | 85 | 7 | 9878537 | ||
| Pubmed | 1.99e-14 | 19 | 85 | 7 | 15689378 | ||
| Pubmed | 3.71e-14 | 10 | 85 | 6 | 9415455 | ||
| Pubmed | 4.63e-13 | 6 | 85 | 5 | 2426947 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 4.63e-13 | 6 | 85 | 5 | 10534397 | |
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 4.63e-13 | 6 | 85 | 5 | 19275937 | |
| Pubmed | 4.63e-13 | 6 | 85 | 5 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 4.63e-13 | 6 | 85 | 5 | 9506531 | |
| Pubmed | 4.63e-13 | 6 | 85 | 5 | 7495302 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 4.63e-13 | 6 | 85 | 5 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 4.63e-13 | 6 | 85 | 5 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 4.63e-13 | 6 | 85 | 5 | 6389236 | |
| Pubmed | 4.63e-13 | 6 | 85 | 5 | 12225806 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 4.63e-13 | 6 | 85 | 5 | 9673377 | |
| Pubmed | 4.63e-13 | 6 | 85 | 5 | 11732842 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.62e-12 | 7 | 85 | 5 | 8006028 | |
| Pubmed | 1.62e-12 | 7 | 85 | 5 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.62e-12 | 7 | 85 | 5 | 10716744 | |
| Pubmed | 1.62e-12 | 7 | 85 | 5 | 7521231 | ||
| Pubmed | 1.62e-12 | 7 | 85 | 5 | 10639489 | ||
| Pubmed | 1.62e-12 | 7 | 85 | 5 | 11711546 | ||
| Pubmed | 1.62e-12 | 7 | 85 | 5 | 1724753 | ||
| Pubmed | 4.31e-12 | 8 | 85 | 5 | 1377218 | ||
| Pubmed | 4.31e-12 | 8 | 85 | 5 | 3997552 | ||
| Pubmed | 4.31e-12 | 8 | 85 | 5 | 29422532 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 4.31e-12 | 8 | 85 | 5 | 11867580 | |
| Pubmed | 4.31e-12 | 8 | 85 | 5 | 10382266 | ||
| Pubmed | 9.68e-12 | 9 | 85 | 5 | 8562707 | ||
| Pubmed | 9.68e-12 | 9 | 85 | 5 | 12101409 | ||
| Pubmed | 9.68e-12 | 9 | 85 | 5 | 10880400 | ||
| Pubmed | 1.93e-11 | 10 | 85 | 5 | 9136074 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 3.32e-11 | 4 | 85 | 4 | 7827955 | |
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.53e-11 | 11 | 85 | 5 | 7500359 | |
| Pubmed | 3.53e-11 | 11 | 85 | 5 | 14998921 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.53e-11 | 11 | 85 | 5 | 9731539 | |
| Pubmed | 6.05e-11 | 12 | 85 | 5 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 6.05e-11 | 12 | 85 | 5 | 15837576 | |
| Pubmed | 6.05e-11 | 12 | 85 | 5 | 16024816 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 6.05e-11 | 12 | 85 | 5 | 12180907 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 9.81e-11 | 13 | 85 | 5 | 9833687 | |
| Pubmed | 1.52e-10 | 14 | 85 | 5 | 12878203 | ||
| Pubmed | 1.66e-10 | 5 | 85 | 4 | 9409248 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.79e-10 | 62 | 85 | 7 | 28344315 | |
| Pubmed | 2.28e-10 | 15 | 85 | 5 | 10625553 | ||
| Pubmed | 2.28e-10 | 15 | 85 | 5 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 2.28e-10 | 15 | 85 | 5 | 10706142 | |
| Pubmed | 3.31e-10 | 16 | 85 | 5 | 15878328 | ||
| Pubmed | 6.47e-10 | 18 | 85 | 5 | 9160753 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 2.31e-09 | 8 | 85 | 4 | 10970885 | |
| Pubmed | 2.31e-09 | 8 | 85 | 4 | 1383086 | ||
| Pubmed | 2.31e-09 | 8 | 85 | 4 | 11683410 | ||
| Pubmed | 2.49e-09 | 210 | 85 | 9 | 16537572 | ||
| Pubmed | 4.15e-09 | 9 | 85 | 4 | 8995276 | ||
| Pubmed | 4.22e-09 | 153 | 85 | 8 | 25037231 | ||
| Pubmed | 4.89e-09 | 26 | 85 | 5 | 24742657 | ||
| Pubmed | 8.39e-09 | 167 | 85 | 8 | 22159717 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRR12 COL4A5 CELSR2 SLC45A3 ZNF335 PKD1 GATA2 EHMT1 ZNRF1 AKAP13 IRS2 LTBP3 BCL9 ZNF839 ZNF687 FAM83H | 9.74e-09 | 1105 | 85 | 16 | 35748872 |
| Pubmed | 1.21e-08 | 175 | 85 | 8 | 28071719 | ||
| Pubmed | 1.25e-08 | 31 | 85 | 5 | 22925884 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 1.41e-08 | 3 | 85 | 3 | 27576055 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 3025878 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 24522496 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 7962065 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 28704582 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 1.41e-08 | 3 | 85 | 3 | 30647093 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 36130833 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 1.41e-08 | 3 | 85 | 3 | 38433557 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 14633121 | ||
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 1.41e-08 | 3 | 85 | 3 | 15954103 | |
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 1.41e-08 | 3 | 85 | 3 | 27859054 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 17396119 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 1.41e-08 | 3 | 85 | 3 | 34049963 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 3089234 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 1.41e-08 | 3 | 85 | 3 | 28542346 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 18930919 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 38978054 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 20301386 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 14507670 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 25575550 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 24033287 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 18050191 | ||
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 2.04e-08 | 34 | 85 | 5 | 16498405 | |
| Pubmed | 3.26e-08 | 14 | 85 | 4 | 19858219 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.35e-08 | 135 | 85 | 7 | 28675934 | |
| Pubmed | 4.76e-08 | 40 | 85 | 5 | 27068110 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 8.76e-08 | 45 | 85 | 5 | 34248495 | |
| Pubmed | 1.93e-07 | 21 | 85 | 4 | 27856617 | ||
| Pubmed | 1.93e-07 | 21 | 85 | 4 | 23325811 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 16192629 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 16041630 | ||
| Pubmed | 3.88e-07 | 186 | 85 | 7 | 20673868 | ||
| Pubmed | 3.88e-07 | 186 | 85 | 7 | 20452482 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 17418794 | ||
| Pubmed | Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy. | 1.17e-06 | 9 | 85 | 3 | 35499085 | |
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 24176640 | ||
| Pubmed | Analysis of candidate genes on chromosome 2 in oral cleft case-parent trios from three populations. | 1.17e-06 | 9 | 85 | 3 | 16953426 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.51e-06 | 79 | 85 | 5 | 18757743 | |
| Pubmed | PRR12 WDR33 GLI2 BCORL1 GATA2 EHMT1 ETV5 ANKRD17 SMARCC2 BCL9 BCOR RFXAP PRRC2A ZNF687 SP7 | 1.79e-06 | 1429 | 85 | 15 | 35140242 | |
| Pubmed | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | 2.29e-06 | 11 | 85 | 3 | 17339318 | |
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 2.56e-06 | 39 | 85 | 4 | 21606205 | |
| Interaction | TGFBI interactions | 4.62e-10 | 25 | 78 | 6 | int:TGFBI | |
| Interaction | HABP2 interactions | 6.28e-09 | 18 | 78 | 5 | int:HABP2 | |
| Interaction | MMP9 interactions | 7.13e-09 | 67 | 78 | 7 | int:MMP9 | |
| Interaction | OSM interactions | 1.13e-08 | 20 | 78 | 5 | int:OSM | |
| Interaction | CD93 interactions | 2.00e-08 | 45 | 78 | 6 | int:CD93 | |
| Interaction | SAA1 interactions | 6.16e-08 | 54 | 78 | 6 | int:SAA1 | |
| Interaction | SERPINE2 interactions | 7.69e-08 | 56 | 78 | 6 | int:SERPINE2 | |
| Interaction | TOP3B interactions | PRR12 COL4A5 CELSR2 UPF2 SLC45A3 ZNF335 CLTA PKD1 GATA2 EHMT1 ZNRF1 ANKRD17 AKAP13 IRS2 LTBP3 BCL9 ZNF839 PRRC2A ZNF687 FAM83H | 5.27e-07 | 1470 | 78 | 20 | int:TOP3B |
| Interaction | DCN interactions | 6.54e-07 | 43 | 78 | 5 | int:DCN | |
| Interaction | ANTXR2 interactions | 4.58e-06 | 29 | 78 | 4 | int:ANTXR2 | |
| Interaction | FBLN2 interactions | 5.67e-06 | 66 | 78 | 5 | int:FBLN2 | |
| Interaction | COL4A2 interactions | 1.07e-05 | 75 | 78 | 5 | int:COL4A2 | |
| Interaction | COL1A2 interactions | 1.29e-05 | 78 | 78 | 5 | int:COL1A2 | |
| Interaction | TLE3 interactions | 1.46e-05 | 376 | 78 | 9 | int:TLE3 | |
| Interaction | NFIB interactions | 1.86e-05 | 142 | 78 | 6 | int:NFIB | |
| Interaction | MMP2 interactions | 2.20e-05 | 87 | 78 | 5 | int:MMP2 | |
| Interaction | NFIX interactions | 2.81e-05 | 227 | 78 | 7 | int:NFIX | |
| Interaction | LHX2 interactions | 7.72e-05 | 183 | 78 | 6 | int:LHX2 | |
| Interaction | MATN2 interactions | 7.73e-05 | 113 | 78 | 5 | int:MATN2 | |
| Interaction | NFIA interactions | 8.95e-05 | 188 | 78 | 6 | int:NFIA | |
| Interaction | FN1 interactions | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL9A1 NPTXR CLTA PKD1 VPS28 MMP9 COL1A2 | 9.60e-05 | 848 | 78 | 12 | int:FN1 |
| Interaction | COL2A1 interactions | 1.11e-04 | 64 | 78 | 4 | int:COL2A1 | |
| Interaction | COL5A1 interactions | 1.18e-04 | 65 | 78 | 4 | int:COL5A1 | |
| Interaction | RCOR1 interactions | 1.21e-04 | 494 | 78 | 9 | int:RCOR1 | |
| Interaction | GATA2 interactions | 1.22e-04 | 199 | 78 | 6 | int:GATA2 | |
| Interaction | KLF15 interactions | 1.31e-04 | 290 | 78 | 7 | int:KLF15 | |
| Interaction | GCM1 interactions | 1.40e-04 | 68 | 78 | 4 | int:GCM1 | |
| Interaction | SP7 interactions | 1.75e-04 | 304 | 78 | 7 | int:SP7 | |
| Interaction | COL5A2 interactions | 1.90e-04 | 29 | 78 | 3 | int:COL5A2 | |
| Interaction | MAG interactions | 1.90e-04 | 29 | 78 | 3 | int:MAG | |
| Interaction | BGN interactions | 2.10e-04 | 30 | 78 | 3 | int:BGN | |
| Interaction | KDM1A interactions | PRR12 MAPT BCORL1 USP24 GATA2 EHMT1 ANKRD17 SMARCC2 IRS2 BCOR ZNF687 SP7 | 2.53e-04 | 941 | 78 | 12 | int:KDM1A |
| Interaction | SOX7 interactions | 2.89e-04 | 82 | 78 | 4 | int:SOX7 | |
| Interaction | ATXN1L interactions | 2.91e-04 | 150 | 78 | 5 | int:ATXN1L | |
| Interaction | GDF2 interactions | 3.07e-04 | 7 | 78 | 2 | int:GDF2 | |
| Interaction | EYA4 interactions | 3.60e-04 | 243 | 78 | 6 | int:EYA4 | |
| Interaction | KDM2B interactions | 4.03e-04 | 161 | 78 | 5 | int:KDM2B | |
| Interaction | BMP3 interactions | 4.08e-04 | 8 | 78 | 2 | int:BMP3 | |
| Interaction | KRTAP7-1 interactions | 4.27e-04 | 38 | 78 | 3 | int:KRTAP7-1 | |
| Interaction | FOXI1 interactions | 4.48e-04 | 92 | 78 | 4 | int:FOXI1 | |
| Cytoband | 8q24.3 | 6.04e-05 | 113 | 85 | 4 | 8q24.3 | |
| Cytoband | 13q34 | 1.42e-04 | 54 | 85 | 3 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 6.00e-04 | 88 | 85 | 3 | chr13q34 | |
| GeneFamily | Collagens | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 COL1A2 | 1.07e-16 | 46 | 55 | 10 | 490 |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.30e-04 | 15 | 55 | 2 | 82 | |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 COL1A2 | 1.16e-16 | 43 | 84 | 10 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 COL1A2 | 1.49e-16 | 44 | 84 | 10 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 LTBP3 COL1A2 | 1.08e-09 | 270 | 84 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 COL5A3 LTBP3 COL1A2 | 1.31e-09 | 275 | 84 | 11 | M5884 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 9.63e-09 | 23 | 84 | 5 | M48001 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.81e-07 | 40 | 84 | 5 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 LTBP3 MMP9 GDF2 COL1A2 | 3.65e-06 | 1008 | 84 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 COL5A3 LTBP3 MMP9 GDF2 COL1A2 | 4.48e-06 | 1026 | 84 | 14 | M5889 |
| Coexpression | KANG_AR_TARGETS_UP | 2.09e-05 | 17 | 84 | 3 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.09e-05 | 17 | 84 | 3 | M2223 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | 7.11e-05 | 554 | 84 | 9 | M2244 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-08 | 176 | 85 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-08 | 176 | 85 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.54e-08 | 180 | 85 | 7 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.19e-08 | 187 | 85 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 8.61e-08 | 192 | 85 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.57e-08 | 195 | 85 | 7 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.90e-08 | 196 | 85 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 9.90e-08 | 196 | 85 | 7 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 197 | 85 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 197 | 85 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 198 | 85 | 7 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 85 | 7 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.30e-07 | 155 | 85 | 6 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-06 | 178 | 85 | 6 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-06 | 186 | 85 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.54e-06 | 186 | 85 | 6 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-06 | 188 | 85 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.78e-06 | 105 | 85 | 5 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.78e-06 | 105 | 85 | 5 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.78e-06 | 105 | 85 | 5 | 62e89b92bb8c5187ab0205aebd018b4178710bb0 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.79e-06 | 191 | 85 | 6 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.79e-06 | 191 | 85 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-06 | 193 | 85 | 6 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.90e-06 | 193 | 85 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-06 | 193 | 85 | 6 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-06 | 194 | 85 | 6 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.96e-06 | 194 | 85 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 195 | 85 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 195 | 85 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.02e-06 | 195 | 85 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.02e-06 | 195 | 85 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 197 | 85 | 6 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-06 | 198 | 85 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 198 | 85 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-06 | 198 | 85 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 2.34e-06 | 200 | 85 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.34e-06 | 200 | 85 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-06 | 142 | 85 | 5 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-06 | 142 | 85 | 5 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 150 | 85 | 5 | 4bdcdce40f54580c7a4e1416b468e657ba8874fc | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 159 | 85 | 5 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 1.35e-05 | 159 | 85 | 5 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 162 | 85 | 5 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-05 | 162 | 85 | 5 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 162 | 85 | 5 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 163 | 85 | 5 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.57e-05 | 164 | 85 | 5 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 1.81e-05 | 169 | 85 | 5 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.81e-05 | 169 | 85 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 169 | 85 | 5 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-05 | 171 | 85 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-05 | 173 | 85 | 5 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-05 | 173 | 85 | 5 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 175 | 85 | 5 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 175 | 85 | 5 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-05 | 175 | 85 | 5 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 175 | 85 | 5 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-05 | 176 | 85 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-05 | 177 | 85 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 177 | 85 | 5 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-05 | 177 | 85 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 177 | 85 | 5 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.33e-05 | 178 | 85 | 5 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 178 | 85 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.39e-05 | 179 | 85 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 179 | 85 | 5 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.45e-05 | 180 | 85 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 181 | 85 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-05 | 181 | 85 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.52e-05 | 181 | 85 | 5 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 181 | 85 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-05 | 182 | 85 | 5 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.66e-05 | 183 | 85 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-05 | 184 | 85 | 5 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-05 | 184 | 85 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 184 | 85 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-05 | 184 | 85 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.73e-05 | 184 | 85 | 5 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 186 | 85 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-05 | 186 | 85 | 5 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 186 | 85 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-05 | 186 | 85 | 5 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.95e-05 | 187 | 85 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-05 | 187 | 85 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.95e-05 | 187 | 85 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 187 | 85 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-05 | 188 | 85 | 5 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-05 | 188 | 85 | 5 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.10e-05 | 189 | 85 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.10e-05 | 189 | 85 | 5 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 189 | 85 | 5 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 189 | 85 | 5 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.10e-05 | 189 | 85 | 5 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 189 | 85 | 5 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-05 | 189 | 85 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| Computational | Genes in the cancer module 256. | 1.28e-04 | 61 | 46 | 4 | MODULE_256 | |
| Drug | BAPN | 1.77e-10 | 71 | 82 | 8 | CID000001647 | |
| Drug | hydroxylysine | COL4A1 COL4A3 COL4A5 COL24A1 COL9A1 COL19A1 ADAMTS2 MMP9 COL1A2 | 2.07e-10 | 109 | 82 | 9 | CID000001029 |
| Drug | DMSe | COL4A1 COL4A3 COL4A5 COL24A1 COL9A1 CELSR2 ADAMTS2 COL5A3 COL1A2 | 1.15e-09 | 132 | 82 | 9 | CID000020796 |
| Drug | 4-hydroxyproline | 1.33e-09 | 91 | 82 | 8 | CID000000825 | |
| Drug | AC1LAKND | 2.54e-09 | 62 | 82 | 7 | CID000470146 | |
| Drug | GK-101 | 3.24e-09 | 36 | 82 | 6 | CID000161853 | |
| Drug | strontium ranelate | 1.19e-08 | 77 | 82 | 7 | CID006918182 | |
| Drug | Madecassol | 1.51e-08 | 46 | 82 | 6 | CID000108062 | |
| Drug | halofuginone lactate | 2.38e-08 | 85 | 82 | 7 | CID000062891 | |
| Drug | d-indobufen | 2.54e-08 | 50 | 82 | 6 | CID000044562 | |
| Drug | ridogrel | 3.23e-08 | 52 | 82 | 6 | CID005362391 | |
| Drug | pirfenidone | 3.63e-08 | 138 | 82 | 8 | CID000040632 | |
| Drug | NSC49633 | 3.63e-08 | 53 | 82 | 6 | CID000023340 | |
| Drug | ticlopidine | 9.08e-08 | 103 | 82 | 7 | CID000005472 | |
| Drug | Tranilast sodium | 1.94e-07 | 115 | 82 | 7 | CID000005527 | |
| Drug | malotilate | 2.15e-07 | 71 | 82 | 6 | CID000004006 | |
| Drug | AC1L1DD6 | 2.71e-07 | 179 | 82 | 8 | CID000002299 | |
| Drug | AC1NMZ1B | 2.99e-07 | 75 | 82 | 6 | CID005034185 | |
| Drug | DL-penicillamine | 7.05e-07 | 139 | 82 | 7 | CID000004727 | |
| Drug | PCR 4099 | 7.05e-07 | 139 | 82 | 7 | CID000002806 | |
| Drug | AC1L1KMJ | COL4A1 COL4A3 COL4A5 COL24A1 COL9A1 SSC4D COL19A1 PKD1 ETV5 MMP9 COL1A2 | 1.09e-06 | 476 | 82 | 11 | CID000030956 |
| Drug | chondroitin sulfate | COL4A1 COL4A3 COL4A5 COL24A1 COL9A1 ARSA COL19A1 MMP9 GDF2 COL1A2 | 2.31e-06 | 413 | 82 | 10 | CID000024766 |
| Drug | khellin | 2.82e-06 | 171 | 82 | 7 | CID000003828 | |
| Drug | AC1L1C2F | 2.88e-06 | 110 | 82 | 6 | CID000001711 | |
| Drug | PPACK | 3.37e-06 | 113 | 82 | 6 | CID003036757 | |
| Drug | AC1L9732 | 3.55e-06 | 114 | 82 | 6 | CID000439300 | |
| Drug | hyaluronan | 4.86e-06 | 263 | 82 | 8 | CID000024759 | |
| Drug | Selara | 6.04e-06 | 125 | 82 | 6 | CID000150310 | |
| Drug | meticrane | 7.28e-06 | 11 | 82 | 3 | CID000004165 | |
| Drug | silibinin | 8.74e-06 | 285 | 82 | 8 | CID000005213 | |
| Drug | colchine | COL4A1 COL4A3 COL4A5 COL24A1 COL9A1 COL19A1 MAPT PKD1 COL1A2 | 9.75e-06 | 383 | 82 | 9 | CID000002833 |
| Drug | candesartan cilexetil | 1.41e-05 | 145 | 82 | 6 | CID000002540 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.76e-05 | 314 | 82 | 8 | CID000447989 | |
| Drug | AC1Q6PCP | 1.96e-05 | 230 | 82 | 7 | CID000005267 | |
| Drug | AC1L18QD | 2.25e-05 | 325 | 82 | 8 | CID000000213 | |
| Drug | NOC 18 | 2.44e-05 | 16 | 82 | 3 | ctd:C093285 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.65e-05 | 162 | 82 | 6 | CID000072363 | |
| Drug | prostacyclin sodium salt | 3.34e-05 | 250 | 82 | 7 | CID000000159 | |
| Drug | CP-331 | 3.84e-05 | 3 | 82 | 2 | CID000130967 | |
| Drug | Pz-plgpa | 4.19e-05 | 19 | 82 | 3 | CID000152296 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 6.27e-05 | 189 | 82 | 6 | CID000001413 | |
| Drug | foscarnet | 6.46e-05 | 190 | 82 | 6 | CID000003414 | |
| Drug | losartan | 6.55e-05 | 378 | 82 | 8 | CID000003961 | |
| Drug | AC1ND30P | 6.60e-05 | 22 | 82 | 3 | CID004568793 | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; PC3; HT_HG-U133A | 7.24e-05 | 194 | 82 | 6 | 5836_UP | |
| Drug | Brn 2557402 | 7.65e-05 | 4 | 82 | 2 | CID000042742 | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; PC3; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 7302_DN | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 7203_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 6097_DN | |
| Drug | dimethylmalonimidate | 1.27e-04 | 5 | 82 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 1.27e-04 | 5 | 82 | 2 | CID006449872 | |
| Drug | 4-fluoranylproline | 1.90e-04 | 6 | 82 | 2 | CID000450594 | |
| Drug | Y-27632 | 1.98e-04 | 444 | 82 | 8 | CID000005711 | |
| Disease | Alport syndrome | 1.78e-08 | 3 | 78 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.78e-08 | 3 | 78 | 3 | cv:CN076135 | |
| Disease | collagen disease (implicated_via_orthology) | 2.20e-08 | 12 | 78 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Hematuria, Benign Familial | 7.09e-08 | 4 | 78 | 3 | C0241908 | |
| Disease | Alport Syndrome | 7.09e-08 | 4 | 78 | 3 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 1.77e-07 | 5 | 78 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.77e-07 | 5 | 78 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.77e-07 | 5 | 78 | 3 | C1567744 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.94e-07 | 53 | 78 | 5 | C4707243 | |
| Disease | Clear cell sarcoma of kidney | 3.53e-07 | 6 | 78 | 3 | C0334488 | |
| Disease | intracranial aneurysm (is_implicated_in) | 3.84e-06 | 12 | 78 | 3 | DOID:10941 (is_implicated_in) | |
| Disease | Developmental Porencephaly | 6.90e-06 | 2 | 78 | 2 | C4082301 | |
| Disease | Congenital porencephaly | 6.90e-06 | 2 | 78 | 2 | C0302892 | |
| Disease | Alport syndrome, recessive type | 6.90e-06 | 2 | 78 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 6.90e-06 | 2 | 78 | 2 | C2931253 | |
| Disease | PORENCEPHALY, FAMILIAL | 6.90e-06 | 2 | 78 | 2 | C1867983 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 6.90e-06 | 2 | 78 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 6.90e-06 | 2 | 78 | 2 | C0403440 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 6.90e-06 | 2 | 78 | 2 | C4551998 | |
| Disease | benign familial hematuria (is_implicated_in) | 6.90e-06 | 2 | 78 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Post-traumatic Porencephaly | 6.90e-06 | 2 | 78 | 2 | C3698507 | |
| Disease | Porencephaly | 6.90e-06 | 2 | 78 | 2 | C4082173 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 6.90e-06 | 2 | 78 | 2 | C3281105 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 6.90e-06 | 2 | 78 | 2 | C4746745 | |
| Disease | Benign familial hematuria | 6.90e-06 | 2 | 78 | 2 | cv:C0241908 | |
| Disease | myopathy (implicated_via_orthology) | 8.05e-06 | 48 | 78 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 2.07e-05 | 3 | 78 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome (is_implicated_in) | 2.07e-05 | 3 | 78 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 2.07e-05 | 3 | 78 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 2.07e-05 | 3 | 78 | 2 | 614519 | |
| Disease | Renal glomerular disease | 3.03e-05 | 23 | 78 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.03e-05 | 23 | 78 | 3 | C4521256 | |
| Disease | Cerebral Hemorrhage | 5.55e-05 | 28 | 78 | 3 | C2937358 | |
| Disease | Endometrial Stromal Sarcoma | 6.86e-05 | 5 | 78 | 2 | C0206630 | |
| Disease | hypertensive nephropathy | 1.03e-04 | 6 | 78 | 2 | C0848548 | |
| Disease | amnestic disorder (implicated_via_orthology) | 2.45e-04 | 9 | 78 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.45e-04 | 9 | 78 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Hematuria | 2.45e-04 | 9 | 78 | 2 | C0018965 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 3.06e-04 | 10 | 78 | 2 | C0268363 | |
| Disease | alkaline phosphatase measurement | 3.36e-04 | 1015 | 78 | 10 | EFO_0004533 | |
| Disease | Global developmental delay | 4.35e-04 | 133 | 78 | 4 | C0557874 | |
| Disease | Amelogenesis Imperfecta | 4.48e-04 | 12 | 78 | 2 | C0002452 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 4.86e-04 | 137 | 78 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 6.15e-04 | 14 | 78 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Hereditary hearing loss and deafness | 6.18e-04 | 146 | 78 | 4 | cv:C0236038 | |
| Disease | fibrinogen measurement, coronary artery disease | 7.54e-04 | 154 | 78 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Craniofacial Abnormalities | 7.91e-04 | 156 | 78 | 4 | C0376634 | |
| Disease | Spondyloepiphyseal Dysplasia | 8.08e-04 | 16 | 78 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 8.08e-04 | 16 | 78 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 8.08e-04 | 16 | 78 | 2 | C4551479 | |
| Disease | Abnormal behavior | 8.08e-04 | 16 | 78 | 2 | C0233514 | |
| Disease | Schwartz-Jampel Syndrome | 8.08e-04 | 16 | 78 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 8.08e-04 | 16 | 78 | 2 | C0025237 | |
| Disease | Dementia | 9.14e-04 | 17 | 78 | 2 | C0497327 | |
| Disease | Van Buchem disease | 9.14e-04 | 17 | 78 | 2 | C0432272 | |
| Disease | neutrophil count | PRUNE2 CELF5 THEM4 MAPT WDR33 BCORL1 PKD1 GATA2 AKAP13 BCL9 SP7 | 9.95e-04 | 1382 | 78 | 11 | EFO_0004833 |
| Disease | Oral Submucous Fibrosis | 1.03e-03 | 18 | 78 | 2 | C0029172 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 1.03e-03 | 18 | 78 | 2 | OBA_2045175 | |
| Disease | Osteochondrodysplasias | 1.15e-03 | 19 | 78 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 1.15e-03 | 19 | 78 | 2 | C0013366 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 1.15e-03 | 19 | 78 | 2 | OBA_2045199 | |
| Disease | coronary artery disease | COL4A1 COL4A2 COL4A4 FOXO6 CELSR2 WDR33 DOK7 ZNF335 AKAP13 MMP9 | 1.17e-03 | 1194 | 78 | 10 | EFO_0001645 |
| Disease | Multiple Epiphyseal Dysplasia | 1.27e-03 | 20 | 78 | 2 | C0026760 | |
| Disease | Osteoarthritis of hip | 1.27e-03 | 20 | 78 | 2 | C0029410 | |
| Disease | hematocrit | 1.38e-03 | 1011 | 78 | 9 | EFO_0004348 | |
| Disease | Osteogenesis imperfecta | 1.40e-03 | 21 | 78 | 2 | cv:C0029434 | |
| Disease | waist-hip ratio | COL4A1 COL4A2 PRUNE2 SEC16B COL24A1 ADAMTS2 MAPT PKD1 COL5A3 LTBP3 | 1.43e-03 | 1226 | 78 | 10 | EFO_0004343 |
| Disease | generalized anxiety disorder | 1.68e-03 | 23 | 78 | 2 | EFO_1001892 | |
| Disease | Cerebral Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0750936 | |
| Disease | Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.99e-03 | 25 | 78 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.99e-03 | 25 | 78 | 2 | C0338070 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 2.15e-03 | 26 | 78 | 2 | OBA_2045194 | |
| Disease | Gemistocytic astrocytoma | 2.15e-03 | 26 | 78 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.15e-03 | 26 | 78 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.15e-03 | 26 | 78 | 2 | C0334582 | |
| Disease | intraocular pressure measurement | 2.30e-03 | 509 | 78 | 6 | EFO_0004695 | |
| Disease | Nephrotic Syndrome | 2.32e-03 | 27 | 78 | 2 | C0027726 | |
| Disease | Retinal Diseases | 2.32e-03 | 27 | 78 | 2 | C0035309 | |
| Disease | Anaplastic astrocytoma | 2.32e-03 | 27 | 78 | 2 | C0334579 | |
| Disease | myocardial infarction | 2.37e-03 | 350 | 78 | 5 | EFO_0000612 | |
| Disease | Disorder of eye | 2.44e-03 | 212 | 78 | 4 | C0015397 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLAGEAAAAPGPGTP | 6 | Q9H7E9 | |
| FPGETGSPGIPGHQG | 851 | Q01955 | |
| VHGLPEGQPRPGGSF | 881 | Q5H9F3 | |
| TGLGGEHEGPAPPAI | 866 | Q12802 | |
| PGDHEDATPGGKGFP | 601 | P53420 | |
| ASGLHDVGPPGPVGI | 1191 | P53420 | |
| SGFPGADGIPGHPGQ | 111 | P08572 | |
| HGFPGAPGQEGPLGL | 841 | P08572 | |
| FPGGAIGRVPAHDPD | 1041 | Q9HCU4 | |
| ELQIHSFGPGPGPGA | 31 | Q9NYJ7 | |
| PIPDGAGGPIFNGPH | 2546 | O75179 | |
| APEGGEGAQPVPGHA | 396 | Q6W2J9 | |
| AAADPPGGPLGHGAE | 41 | O95450 | |
| PGEHGAIGPPGLQGI | 766 | P02462 | |
| AVAATGPPKHAPGAG | 371 | Q6UXK2 | |
| LGPGPGLQASFGPHA | 136 | Q96IS3 | |
| VPEGPFPGHLVDVSG | 726 | Q9Y5E4 | |
| NAHSPLGVPGGGLPE | 36 | Q9UK05 | |
| GLLAHAFPPGPGIQG | 186 | P14780 | |
| LHGPDPVPGAAGSAA | 126 | Q5VV17 | |
| GGGGPTVPPHQEAAS | 26 | Q7L2J0 | |
| PGGGPVAPAEDHHEG | 321 | Q8NAA5 | |
| RAPGPGGADGVPHID | 71 | Q32MK0 | |
| GDGVPGPAQAFPGHL | 226 | Q32MK0 | |
| AGLAPPGHAAAFGGP | 391 | A8MYZ6 | |
| AVRGAGVAGPAAHPG | 56 | Q4G148 | |
| AGAAPAFPHEAPGGG | 951 | P10070 | |
| GHAPAAGPVQGVGPA | 161 | P41161 | |
| LGVGPEGAFLPPHQG | 126 | P15289 | |
| HPFVPFGFGGSPDGL | 11 | A6NEQ2 | |
| ALHGAGGSAGPPALP | 61 | O95502 | |
| VPEGPFPGHLVDVSG | 726 | Q9Y5E5 | |
| PGAPSGHPVGSLDGL | 991 | Q9Y4H2 | |
| AGHLGPSPAGPVGIN | 446 | P0CG12 | |
| LHPSAAGGPGGPLSV | 126 | P23769 | |
| HGEFGLPGPAGPRGE | 576 | P08123 | |
| PGFGGSPVPVGIDVH | 76 | A8MPY1 | |
| EPGENGLHGAPGFPG | 311 | Q14993 | |
| PGVHGSPGDIGPQGI | 611 | Q14993 | |
| GPRTDVGAPFGPQGH | 421 | O00512 | |
| VGAPFGPQGHRDVPF | 426 | O00512 | |
| FAGVVPFPGGHPALE | 321 | Q8N6W0 | |
| PKGEPGFHGFPGVQG | 1221 | P29400 | |
| GPGEGPPAQHAAFLV | 196 | Q9NS15 | |
| PPALDELGGPGGVTH | 186 | Q96QS3 | |
| PGPRGTIGFHDGDPL | 396 | P20849 | |
| EAGGPHAGPPPAFFS | 476 | Q18PE1 | |
| LGAGPRFPELGPDGH | 491 | Q6ZRV2 | |
| VEGTFPPPGFGLAHV | 6 | Q9Y5M1 | |
| PDFHAVLAGPGGPGN | 1046 | Q13255 | |
| HVPEGFDPTGPAGLG | 691 | Q9H9B1 | |
| GDFGHVGQPGPPGED | 566 | P25940 | |
| GAVLPPGFRPHFEVG | 2536 | P98161 | |
| EHGPGIDIFTPGKPG | 436 | Q9HAU5 | |
| APGPAHGPLLVTAGA | 156 | Q8IVF1 | |
| APGPAHGPLLVTAGA | 156 | A6NNL0 | |
| APGPAHGPLLVTAGA | 156 | B1AL46 | |
| FPVAIGDPLFHGPGL | 261 | Q14D33 | |
| PVGEGAGPHHTLLPG | 451 | Q8WUY3 | |
| GGGEAVETHPAPGPL | 31 | Q7Z572 | |
| LFVVGPESAGAHPGP | 366 | O14841 | |
| FGPDGGLVSNAPHIP | 776 | O14841 | |
| PVLGGGEPPFHGHRD | 376 | Q9BXW7 | |
| AAAEGAPAAPPGHGE | 336 | Q8NDX1 | |
| PHFEEPGPMVRGVGG | 1531 | P48634 | |
| VAEGAGPGAASGVPH | 6 | O00287 | |
| GPGAASGVPHPAALA | 11 | O00287 | |
| AVPHPPPSGAFGLGG | 1331 | Q9ULL5 | |
| GAAGPPAVHGLAVAP | 976 | Q8TAQ2 | |
| KPGAPFPNGHVGAGG | 436 | Q96JT2 | |
| FEPGKPPGDTHGQVG | 346 | Q13705 | |
| AFAILDGGAPGPQPH | 51 | P09496 | |
| AAGPLSAPIIAGGHP | 71 | Q8N7H1 | |
| GPDGEPGIPGYRGHQ | 1161 | Q17RW2 | |
| EPAEPGAHGGPSTFG | 1151 | Q9UPX0 | |
| AGIHAGISPGPGNTP | 141 | Q8TDD2 | |
| AAPGEAHFGPGRGPI | 521 | Q8WTU2 | |
| GPYLEGPPGFIHGGA | 141 | Q5T1C6 | |
| MFHGIPATPGIGAPG | 1 | Q9UK41 | |
| HLGRAAFPGAPGEGP | 321 | P10636 | |
| PVSFGPGGQLVHVGP | 281 | Q96JE7 | |
| ESLPPGGPGHAEAGH | 641 | A8K0R7 | |
| FHLGGPGLPGHAGPC | 111 | Q6ZR54 | |
| GGGGFDPPPAYHEVV | 91 | Q9UPU5 | |
| AIHSGPEENEGPGGP | 26 | Q8N1G0 | |
| PPPAAGFGVHRGAFL | 11 | Q96HZ7 | |
| EQSGGPEHGPERGPF | 976 | Q9C0J8 | |
| VSHGPVAGVTGGPPA | 91 | Q9H4Z2 | |
| AAGGAPHIGFVGEPP | 91 | A0A1B0GWB2 | |
| SPADAVGGPAAHPGG | 176 | P0C6A0 | |
| ALQPHGVPGDGEGPH | 516 | Q9ULE0 | |
| DDSAVPPPGGAPHFG | 21 | Q8ND25 | |
| SLGGPEGAHPAAAPA | 116 | Q8TDC0 |